Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001085
UniProt IDQ8IVF7
Primary gene name(s)FMNL3
Synonym gene name(s)FHOD3, FRL2, KIAA2014, WBP3
Protein nameFormin-like protein 3
Protein functionPlays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. Required for developmental angiogenesis, By similarity. In this process, required for microtubule reorganization and for efficient endothelial cell elongation. In quiescent endothelial cells, triggers rearrangement of the actin cytoskeleton, but does not alter microtubule alignement. {ECO:0000250|UniProtKB:Q6NXC0, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22275430}.
Subcellular locationCytoplasm {ECO:0000269|PubMed:21834987}. Cell membrane {ECO:0000269|PubMed:22275430};
Lipid-anchor {ECO:0000255}. Note=Enriched in lamellipodia.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q8IVF7
Gene Ontology
(Biological Process)
Complete annatation
actin cytoskeleton organization [GO:0030036];
angiogenesis [GO:0001525];
cell migration [GO:0016477];
cytoskeleton organization [GO:0007010];
regulation of cell shape [GO:0008360]
Gene Ontology
(Molecular Function)
Complete annatation
GTPase activating protein binding [GO:0032794]
Gene Ontology
(Cellular Component)
Complete annatation
cytoplasm [GO:0005737];
cytosol [GO:0005829];
plasma membrane [GO:0005886]
Protein-protein interaction124787
Phylogenetic treeQ8IVF7
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.1879889101208130.6179806479406710.719861010108437
AZA vs. DISU-0.01455202193412140.9541029333828190.996649735504266
AZA vs. IL7-0.2273328341865560.236304667537960.990920320206469
AZA vs. SAHA-0.01413028607357830.9537214487948160.990329939023704
DISU vs. CD3-0.2153341815384680.5754651540633030.690979905396704
DISU vs. IL7-0.2220109414439490.3782058655653220.749500910135037
DISU vs. SAHA0.002104651845242910.9942355406996150.999572425883731
DMSO vs. AZA0.03881308109771390.8162997686421521
DMSO vs. CD3-0.1612742767897060.6678743381294980.754121038263718
DMSO vs. DISU0.05134577585885910.8331842566621330.98169359789001
DMSO vs. IL7-0.2587152787629750.1496016511617120.65123143216418
DMSO vs. SAHA-0.05916962657117230.8014673884052630.944454878132789
HIV vs. Mock in Activation0.3186981147607290.7024295381072260.999983755607037
HIV vs. Mock in Latency-0.01998026312469910.9034258063693820.999834320637052
IL7 vs. CD3-0.4087769153719150.2743792979755270.409801739832056
SAHA vs. CD3-0.2272168826369260.5423278798118160.647510786623678
SAHA vs. IL70.2096594892560550.3886366019849420.638429037659881
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change 1.618780217
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.23283 0.0927146
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.115 1.074 1.923 2.832 2.56
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found